What is MapLight Therapeutics, Inc. 's net change in cash?

MapLight Therapeutics, Inc. (MPLT) reported net change in cash of $8.98M in Q1 2026.

How has MapLight Therapeutics, Inc. 's net change in cash changed year-over-year?

MapLight Therapeutics, Inc. 's net change in cash decreased by 24.6% year-over-year, from $11.9M to $8.98M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

MapLight Therapeutics, Inc. MPLT Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

Johnson & JohnsonJNJ

$1.98B-86.2%

Neurocrine BiosciencesNBIX

-$446.5M-1,048%

Acadia PharmaceuticalsACAD

$104.52M+203%

AbbVieABBV

$4.16B+1,293%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$70.51M+2,340%

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's net change in cash?: MapLight Therapeutics, Inc. (MPLT) reported net change in cash of $8.98M in Q1 2026.
How has MapLight Therapeutics, Inc. 's net change in cash changed year-over-year?: MapLight Therapeutics, Inc. 's net change in cash decreased by 24.6% year-over-year, from $11.9M to $8.98M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.